Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    A 3D SUPRAMOLECULAR POLYMER INVOLVING HYDROGEN BONDS BASED ON NICKEL(II), 1,3-BENZENEDICARBOXYLIC ACID, AND A NITROGEN-CONTAINING LIGAND

    The [Ni(1,3-bdc)(L)(H2O)2]n·2nH2O (1) coordination polymer (1,3-H2bdc = 1,3-benzenedicarboxylic acid, L = 4,4′-N,N′-bis(3-pyridylformamide)diphenyl ether) is hydrothermally synthesized and structurally characteri...

    Y. Song, L. P. Xu, G. T. Li, X. Y. Wang in Journal of Structural Chemistry (2021)

  2. No Access

    Article

    Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia

    We conducted a retrospective analysis to evaluate outcomes of haploidentical transplantation in adult severe aplastic anaemia (SAA) patients. Fifty-one adults received haploidentical transplantation between Ma...

    L-P Xu, Z-L Xu, F-R Wang, X-D Mo, T-T Han, W Han, Y-H Chen in Bone Marrow Transplantation (2018)

  3. No Access

    Article

    Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants

    Prior data indicate similar outcomes after transplants from human leukocyte antigen (HLA)-haplotype-matched relatives, HLA-identical siblings and HLA-matched unrelated donors. We used our prospective data set ...

    Y Wang, D-P Wu, Q-F Liu, L-P Xu, K-Y Liu, X-H Zhang, Y Xu, F Huang, X-J Huang in Leukemia (2018)

  4. No Access

    Article

    Correlation between pediatric donor characteristics and cell compositions in mixture allografts of combined G-CSF-mobilized PBSCs and bone marrow allografts

    L-Q Cao, L Liu, L-P Xu, X-H Zhang, Y Wang, Q-Z Fan, Y-R Liu in Bone Marrow Transplantation (2018)

  5. No Access

    Article

    A review of hematopoietic cell transplantation in China: data and trends during 2008–2016

    Hematopoietic cell transplantation (HCT) activity in China was surveyed to assess its current status. A record number of HCTs (21 884: 16 631 allogeneic (76%) and 5253 autologous (24%)) were reported by 76 cen...

    L-P Xu, D-P Wu, M-Z Han, H Huang, Q-F Liu, D-H Liu, Z-M Sun in Bone Marrow Transplantation (2017)

  6. No Access

    Article

    Immune reconstitution in patients with acquired severe aplastic anemia after haploidentical stem cell transplantation

    Immune recovery (IR) after haploidentical stem cell transplantation (haplo-SCT) in severe aplastic anemia (SAA) patients remains relatively unknown. In this study, we examined immune cell subset counts and imm...

    X-Y Pei, X-Y Zhao, L-P Xu, Y Wang, X-H Zhang, Y-J Chang in Bone Marrow Transplantation (2017)

  7. No Access

    Article

    Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation

    We investigated the impact of donor type on post-relapse survival (PRS) in 85 patients with hematological relapse after their first allogeneic hematological stem cell transplantation (allo-HSCT) for hematologi...

    Y-R Ma, L-P Xu, X-H Zhang, C-H Yan, Y Wang, F-R Wang in Bone Marrow Transplantation (2017)

  8. No Access

    Article

    Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia

    Techniques for haploidentical hematopoietic stem cell transplantation (haplo-HSCT) to treat severe aplastic anemia (SAA) have recently improved, but no protocol has been evaluated in a large number of pediatri...

    L P Xu, X H Zhang, F R Wang, X D Mo, T T Han, W Han in Bone Marrow Transplantation (2017)

  9. No Access

    Article

    Association of Epstein–Barr virus reactivation with the recovery of CD4/CD8 double-negative T lymphocytes after haploidentical hematopoietic stem cell transplantation

    EBV infection is one of the life-threatening clinical complications in patients who underwent haploidentical hematopoietic stem cell transplantation (haploHSCT). Although immune recovery is recognized to be cr...

    Z Bian, J Liu, L-P Xu, Y-J Chang, Y Wang, X-H Zhang in Bone Marrow Transplantation (2017)

  10. No Access

    Article

    Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant

    Encouraging results from a small sample of patients with myelodysplastic syndrome (MDS) undergoing haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT) must be extended. Furthermore, an al...

    Y Wang, H-X Wang, Y-R Lai, Z-M Sun, D-P Wu, M Jiang, D-H Liu, K-L Xu, Q-F Liu in Leukemia (2016)

  11. Article

    Open Access

    CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor

    Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been established as an effective treatment for patients with hematological malignancies. Disease relapse remains a major cause of transplant f...

    X.-Y. Qin, Y. Wang, G.-X. Li, Y.-Z. Qin, F.-R. Wang in Journal of Translational Medicine (2016)

  12. No Access

    Article

    Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation

    This study was performed to investigate incidence, causes and factors influencing mortality after haploidentical hematopoietic stem cell transplantation (HSCT) and to compare differences between haploidentical...

    C-H Yan, L-P Xu, F-r Wang, H Chen, W Han, Yu Wang, J-z Wang in Bone Marrow Transplantation (2016)

  13. No Access

    Article

    A retrospective comparison of BU-fludarabine and BU–CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCT

    Y-q Sun, L-p Xu, X-h Zhang, D-h Liu, H Chen, Y Wang, C-h Yan in Bone Marrow Transplantation (2015)

  14. No Access

    Article

    Presence of CD34+CD38CD58 leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCT

    Relapse of Ph chromosome-positive ALL (Ph+ALL) results from the persistence of leukemia-propagating cells (LPCs). In Ph+ALL, a xenograft assay recently determined that LPCs are enriched in the CD34+CD38CD58 fra...

    Y Kong, L-P Xu, Y-R Liu, Y-Z Qin, Y-Q Sun, Y Wang, H Jiang in Bone Marrow Transplantation (2015)

  15. No Access

    Article

    Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome

    The aim of this study was to investigate the impact of occurrence of chronic GVHD (cGVHD) and its severity on transplantation outcomes in a consecutive cohort of AML and myelodysplastic syndrome (MDS) patients...

    X-D Mo, L-P Xu, X-H Zhang, D-H Liu, Y Wang, H Chen, C-H Yan in Bone Marrow Transplantation (2015)

  16. No Access

    Article

    Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALL

    Only 30% of high-risk adult ALL patients in their first complete remission (CR1) are able to receive an HLA-matched sibling stem cell transplant. The role of haploidentical hematopoietic SCT (haplo-HSCT) in po...

    Y-q Sun, J Wang, Q Jiang, L-p Xu, D-h Liu, X-h Zhang in Bone Marrow Transplantation (2015)

  17. No Access

    Article

    Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCT

    This study evaluates the prognostic significance of quantitative chimerism to monitor minimal residual disease and predict relapse in acute leukemia (AL) patients following allogeneic hematopoietic SCT (HSCT)....

    X-Y Qin, G-X Li, Y-Z Qin, Y Wang, F-R Wang, D-H Liu, L-P Xu in Bone Marrow Transplantation (2014)

  18. Article

    Open Access

    HLA and KIR genoty** correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients

    Conflicting results have been reported regarding the predicative roles of alloreactive natural killer (NK) cells on the outcomes of transplantation in leukaemia patients.

    X-Y Zhao, Y-J Chang, L-P Xu, X-H Zhang, K-Y Liu, D Li in British Journal of Cancer (2014)

  19. No Access

    Article

    Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis

    CML treatment with tyrosine kinase inhibitors (TKIs) has improved many patients’ prognosis, but during the disease’s terminal phase, the blast crisis (CML-BC), has been disappointing. Allo-HSCT is another trea...

    H Jiang, L-P Xu, D-H Liu, K-Y Liu, S-S Chen, B Jiang in Bone Marrow Transplantation (2014)

  20. No Access

    Article

    Umbilical cord blood transplantation and unmanipulated haploidentical hematopoietic SCT for pediatric hematologic malignances

    This study aimed to compare the therapeutic effects of single umbilical cord blood transplantation (UCBT) and unmanipulated haploidentical hematopoietic SCT (haplo-HSCT) in childhood hematologic malignances. W...

    X-D Mo, X-Y Zhao, D-H Liu, Y-H Chen, L-P Xu, X-H Zhang in Bone Marrow Transplantation (2014)

previous disabled Page of 3